Get In Touch

Somatotropin is a type of drug used as a medication against the growth and regeneration among humans and also stimulates cell reproduction. Deficiency of growth hormones is rising across the globe. Advancements in technology including development of recombinant human growth hormone by the major players is boosting the growth of the somatotropin market. Moreover, the leading companies are focusing on raising production capacity in order to increase supply in rural areas. Somatropin is a recombinant form of growth hormone and is provided only as a prescription drug for the treatment of adult growth hormone and disorders related to child growth. In the U.S., it is only available at a pharmacy store on physician’s prescription. Physicians in the U.S. have begun to prescribe somatotropin to older patients for some growth defects, but not to healthy individuals.

The global somatotropin drugs market can be segmented based on product type, application, route of administration, and distribution channel. In terms of product type, the global market can be bifurcated into powder and solvent. Based on application, the global somatotropin drug market can be classified into Turner’s syndrome, growth hormone deficiency, Prader-Willi syndrome, chronic renal insufficiency, idiopathic short stature, small for gestational age, and others. The growth hormone deficiency segment is expected to witness strong growth during the forecast period. Pituitary tumors, metabolic abnormalities, and skeletal abnormalities are the primary causes of growth hormone deficiency. Adults with growth hormone deficiency are also increasingly taking growth hormone injections, as these protect them from increased muscle mass, fractures, and also reduce the risk of heart diseases. In terms of route of administration, the global somatotropin drug market can be categorized into intramuscular, intravenous, and subcutaneous. The subcutaneous segment is likely to witness substantial growth during the forecast period owing to significant rise in growth rates and low incidence of antibody development. Moreover, subcutaneous route is highly preferred for chronic growth hormone therapy. Based on distribution channel, the global market can be divided into hospital pharmacies, retail pharmacies, online pharmacies, and clinics. Hospital pharmacies is likely to be the largest distribution channel segment of the global somatotropin market. This is attributed to high cost of human growth hormone drugs. Moreover, high investment in the development of advanced health care centers and hospitals by governments in various countries drives the distribution of growth hormone drugs through hospital pharmacies.

Geographically, the somatotropin drug market can be segmented into five major regions: North America, Middle East & Africa, Latin America, Asia Pacific, and Europe. North America is the leading market for somatotropin drug in terms of revenue, followed by Europe. The U.S. held the largest share of the market in North America. Asia Pacific and Latin America are emerging markets and are expected to witness significant growth during the forecast period. High growth rates in these regions are attributable to increase in number of people having growth hormone deficiency. The somatotropin drug market in countries such as China, India, and Brazil is projected to expand at a rapid pace during the forecast period due to increase in awareness among the population about growth hormone deficiency treatment.

Major players operating in the global somatotropin drug market include Merck KGaA, Eli Lilly and Company, Novo Nordisk A/S, Anhui Anke Biotechnology Co., Ltd., Ipsen S.A., GeneScience Pharmaceuticals Co., Ltd., Roche Holdings, Inc., Pfizer Inc., Novartis AG, and Biopartners GmbH.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Somatotropin Market

Pre Book